Data / Drug companies / Grocery Outlet, Inc.
Grocery Outlet, Inc.: 46 products in the FDA NDC directory, labeler code 85828
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Grocery Outlet, Inc. (labeler code 85828) lists 46 products in the FDA National Drug Code Directory, covering 29 finished drugs by generic name. By type: 46 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 5, 2026.
The request: Watch Grocery Outlet, Inc. (FDA labeler code 85828): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85828
- Products in commercial distribution
- 46
- Packages
- 46
- Finished drugs by generic name
- 29
- Prescription products
- 0
- Over the counter products
- 46
- Flagged as original packager
- 46 of 46 products that carry the flag
- Started marketing in the last 12 months
- 44
- Earliest marketing start
- October 13, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 31 | 67.4% |
| Generic drugs (ANDA) | 15 | 32.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 46 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 5 | 214 |
| Ibuprofen | 3 | 190 |
| Bismuth subsalicylate | 2 | 80 |
| Isopropyl alcohol | 2 | 177 |
| Calcium carbonate | 2 | 101 |
| Loperamide hcl | 1 | 42 |
| Doxylamine succinate | 1 | 39 |
| Aspirin 81 mg | 1 | 5 |
| Nighttime cold and flu relief | 1 | 1 |
| Simethicone | 1 | 86 |
| Omeprazole 20 mg | 1 | 2 |
| Diphenhydramine hydrochloride | 1 | 127 |
| Chewable aspirin | 1 | 1 |
| Loratadine | 1 | 125 |
| Benzalkonium chloride | 1 | 271 |
| Bisacodyl 5mg | 1 | 4 |
| Guaifenesin | 1 | 123 |
| Allergy relief | 1 | 4 |
| Acetaminophen, aspirin and caffeine | 1 | 26 |
| Cetirizine hydrochloride | 1 | 119 |
| Naproxen sodium 220mg | 1 | 5 |
| Famotidine 20mg | 1 | 3 |
| Hydrogen peroxide | 1 | 100 |
| Acetaminophen and diphenhydramine hydrochloride | 1 | 29 |
| Fluticasone propionate | 1 | 71 |
| Magnesium sulfate | 1 | 40 |
| Esomeprazole magnesium | 1 | 77 |
| Fexofenadine hydrochloride | 1 | 65 |
| Diphenhydramine hcl 50mg | 1 | 3 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, coated | 9 | 19.6% |
| Liquid | 7 | 15.2% |
| Tablet | 6 | 13% |
| Tablet, chewable | 4 | 8.7% |
| Capsule | 3 | 6.5% |
| Kit | 3 | 6.5% |
| Tablet, extended release | 2 | 4.3% |
| Suspension | 2 | 4.3% |
| Tablet, film coated | 2 | 4.3% |
| Capsule, liquid filled | 2 | 4.3% |
| Tablet, delayed release | 1 | 2.2% |
| Cloth | 1 | 2.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| 24 HOUR Esomeprazole Magnesium | 85828-718 | Capsule, delayed release | Generic drugs (ANDA) | June 5, 2026 |
| Go home and haven antibacterial hand wipes | 85828-301 | Cloth | Over the counter monograph drugs | June 1, 2026 |
| Nighttime Cold and Flu | 85828-750 | Liquid | Over the counter monograph drugs | March 25, 2026 |
| 24 HOUR Omeprazole | 85828-731 | Tablet, delayed release | Generic drugs (ANDA) | March 25, 2026 |
| Extra Strength Gas Relief | 85828-722 | Capsule | Over the counter monograph drugs | March 25, 2026 |
| Nighttime Cold and Flu Relief | 85828-418 | Capsule | Over the counter monograph drugs | March 25, 2026 |
| Daytime Cold and Flu | 85828-417 | Capsule | Over the counter monograph drugs | March 25, 2026 |
| Nighttime Severe Cold and Flu | 85828-775 | Liquid | Over the counter monograph drugs | March 24, 2026 |
| Daytime Severe Cold and Flu | 85828-774 | Liquid | Over the counter monograph drugs | March 24, 2026 |
| Ultra Strength Antacid | 85828-905 | Tablet, chewable | Over the counter monograph drugs | March 20, 2026 |
| Extra Strength Antacid | 85828-903 | Tablet, chewable | Over the counter monograph drugs | March 20, 2026 |
| Stomach Relief | 85828-791 | Suspension | Over the counter monograph drugs | March 20, 2026 |
| Daytime Cold and Flu | 85828-772 | Liquid | Over the counter monograph drugs | March 20, 2026 |
| Acid Reducer Maximum Strength | 85828-443 | Tablet | Generic drugs (ANDA) | March 20, 2026 |
| Chewable Aspirin Low Dose | 85828-288 | Tablet, chewable | Over the counter monograph drugs | March 20, 2026 |
| Laxative Enteric Coated | 85828-404 | Tablet, coated | Over the counter monograph drugs | March 19, 2026 |
| Aspirin Enteric Coated | 85828-372 | Tablet | Over the counter monograph drugs | March 19, 2026 |
| Anti-Diarrheal | 85828-248 | Tablet, coated | Generic drugs (ANDA) | March 19, 2026 |
| Nighttime Sleep Aid | 85828-439 | Tablet | Generic drugs (ANDA) | March 18, 2026 |
| Naproxen Sodium 220mg | 85828-394 | Tablet, film coated | Generic drugs (ANDA) | March 18, 2026 |
| Nighttime Sleep Aid | 85828-410 | Capsule, liquid filled | Over the counter monograph drugs | March 17, 2026 |
| Headache Relief Extra Strength | 85828-285 | Tablet, film coated | Over the counter monograph drugs | March 17, 2026 |
| Fluticasone Propionate | 85828-448 | Spray, metered | Generic drugs (ANDA) | March 16, 2026 |
| Allergy Relief | 85828-048 | Tablet, coated | Over the counter monograph drugs | March 16, 2026 |
| Mucus Relief | 85828-723 | Tablet, extended release | Generic drugs (ANDA) | March 13, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.